Literature DB >> 22348240

Clinical metabolomics paves the way towards future healthcare strategies.

Sebastiano Collino1, François-Pierre J Martin, Serge Rezzi.   

Abstract

Metabolomics is recognized as a powerful top-down system biological approach to understand genetic-environment-health paradigms paving new avenues to identify clinically relevant biomarkers. It is nowadays commonly used in clinical applications shedding new light on physiological regulatory processes of complex mammalian systems with regard to disease aetiology, diagnostic stratification and, potentially, mechanism of action of therapeutic solutions. A key feature of metabolomics lies in its ability to underpin the complex metabolic interactions of the host with its commensal microbial partners providing a new way to define individual and population phenotypes. This review aims at describing recent applications of metabolomics in clinical fields with insight into diseases, diagnostics/monitoring and improvement of homeostatic metabolic regulation.
© 2012 Nestec Ltd. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22348240      PMCID: PMC3575929          DOI: 10.1111/j.1365-2125.2012.04216.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  90 in total

1.  Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action.

Authors:  Jiekun Xuan; Guihua Pan; Yunping Qiu; Lun Yang; Mingming Su; Yumin Liu; Jian Chen; Guoyin Feng; Yiru Fang; Wei Jia; Qinghe Xing; Lin He
Journal:  J Proteome Res       Date:  2011-11-08       Impact factor: 4.466

Review 2.  Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics.

Authors:  F Shanahan
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

3.  Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry.

Authors:  Christer S Ejsing; Julio L Sampaio; Vineeth Surendranath; Eva Duchoslav; Kim Ekroos; Robin W Klemm; Kai Simons; Andrej Shevchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

4.  Application of biofluid 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile.

Authors:  Kirty S Solanky; Nigel J C Bailey; Bridgette M Beckwith-Hall; Adrienne Davis; Sheila Bingham; Elaine Holmes; Jeremy K Nicholson; Aedin Cassidy
Journal:  Anal Biochem       Date:  2003-12-15       Impact factor: 3.365

5.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Authors:  Arun Sreekumar; Laila M Poisson; Thekkelnaycke M Rajendiran; Amjad P Khan; Qi Cao; Jindan Yu; Bharathi Laxman; Rohit Mehra; Robert J Lonigro; Yong Li; Mukesh K Nyati; Aarif Ahsan; Shanker Kalyana-Sundaram; Bo Han; Xuhong Cao; Jaeman Byun; Gilbert S Omenn; Debashis Ghosh; Subramaniam Pennathur; Danny C Alexander; Alvin Berger; Jeffrey R Shuster; John T Wei; Sooryanarayana Varambally; Christopher Beecher; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

6.  Topographical variation in murine intestinal metabolic profiles in relation to microbiome speciation and functional ecological activity.

Authors:  Francois-Pierre J Martin; Yulan Wang; Ivan K S Yap; Norbert Sprenger; John C Lindon; Serge Rezzi; Sunil Kochhar; Elaine Holmes; Jeremy K Nicholson
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

Review 7.  A role for inflammation in irritable bowel syndrome?

Authors:  G Barbara; R De Giorgio; V Stanghellini; C Cremon; R Corinaldesi
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 8.  Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.

Authors:  Elisa Fabbrini; Shelby Sullivan; Samuel Klein
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

9.  Exercise-induced changes in metabolic intermediates, hormones, and inflammatory markers associated with improvements in insulin sensitivity.

Authors:  Kim M Huffman; Cris A Slentz; Lori A Bateman; Dana Thompson; Michael J Muehlbauer; James R Bain; Robert D Stevens; Brett R Wenner; Virginia Byers Kraus; Christopher B Newgard; William E Kraus
Journal:  Diabetes Care       Date:  2010-10-04       Impact factor: 19.112

10.  Metabolic regulation in progression to autoimmune diabetes.

Authors:  Marko Sysi-Aho; Andrey Ermolov; Peddinti V Gopalacharyulu; Abhishek Tripathi; Tuulikki Seppänen-Laakso; Johanna Maukonen; Ismo Mattila; Suvi T Ruohonen; Laura Vähätalo; Laxman Yetukuri; Taina Härkönen; Erno Lindfors; Janne Nikkilä; Jorma Ilonen; Olli Simell; Maria Saarela; Mikael Knip; Samuel Kaski; Eriika Savontaus; Matej Orešič
Journal:  PLoS Comput Biol       Date:  2011-10-27       Impact factor: 4.475

View more
  23 in total

Review 1.  Metabolomics: Applications and Promise in Mycobacterial Disease.

Authors:  Mehdi Mirsaeidi; Mohammad Mehdi Banoei; Brent W Winston; Dean E Schraufnagel
Journal:  Ann Am Thorac Soc       Date:  2015-09

2.  Nutraceuticals: is there good science behind the hype?

Authors:  Jeroen Schmitt; Albert Ferro
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

Review 3.  Blood type biochemistry and human disease.

Authors:  D Rose Ewald; Susan C J Sumner
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-09-07

Review 4.  UPLC-MS for metabolomics: a giant step forward in support of pharmaceutical research.

Authors:  Ala F Nassar; Terence Wu; Samuel F Nassar; Adam V Wisnewski
Journal:  Drug Discov Today       Date:  2016-12-02       Impact factor: 7.851

5.  Lung cancer metabolomic data from tumor core biopsies enables risk-score calculation for progression-free and overall survival.

Authors:  Hunter A Miller; Shesh N Rai; Xinmin Yin; Xiang Zhang; Jason A Chesney; Victor H van Berkel; Hermann B Frieboes
Journal:  Metabolomics       Date:  2022-05-14       Impact factor: 4.290

6.  Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock.

Authors:  Michael A Puskarich; Michael A Finkel; Alla Karnovsky; Alan E Jones; Julie Trexel; Brooke N Harris; Kathleen A Stringer
Journal:  Ann Am Thorac Soc       Date:  2015-01

7.  Metabolic profiling, a noninvasive approach for the detection of experimental colorectal neoplasia.

Authors:  David C Montrose; Xi Kathy Zhou; Levy Kopelovich; Rhonda K Yantiss; Edward D Karoly; Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2012-09-07

8.  An analysis of a 'community-driven' reconstruction of the human metabolic network.

Authors:  Neil Swainston; Pedro Mendes; Douglas B Kell
Journal:  Metabolomics       Date:  2013-07-12       Impact factor: 4.290

Review 9.  NGAL and metabolomics: the single biomarker to reveal the metabolome alterations in kidney injury.

Authors:  A Noto; F Cibecchini; V Fanos; M Mussap
Journal:  Biomed Res Int       Date:  2013-03-27       Impact factor: 3.411

Review 10.  Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery.

Authors:  Douglas B Kell; Royston Goodacre
Journal:  Drug Discov Today       Date:  2013-07-26       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.